James William Burns Agios Pharmaceuticals, Inc. (AGIO) insider trading activity

James William Burns is Chief Legal Officer of AGIOS PHARMACEUTICALS, INC.. Currently has a direct ownership of 15,700 shares of AGIO, which is worth approximately $524,380. The most recent transaction as insider was on Nov 07, 2024, when has been sold 21,752 shares (Common Stock) at a price of $52.28 per share, resulting in proceeds of $1,137,194. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.7K

57.76% 3M change

34.28% 12M change

Total Value Held $524,380

James William Burns Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 07 2024	SELL Open market or private sale	$1,137,194 $52.28 p/Share	21,752 Reduced 58.08%	15,700 Common Stock
Mar 05 2024	SELL Open market or private sale	$86,049 $32.57 p/Share	2,642 Reduced 6.64%	37,169 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	-	7,834 Added 16.9%	38,518 Common Stock
Feb 14 2024	SELL Open market or private sale	$13,701 $25.14 p/Share	545 Reduced 1.69%	31,666 Common Stock
Feb 12 2024	BUY Exercise of conversion of derivative security	-	1,833 Added 5.38%	32,211 Common Stock
Jan 24 2024	SELL Open market or private sale	$36,961 $21.64 p/Share	1,708 Reduced 5.32%	30,378 Common Stock
Jan 20 2024	BUY Exercise of conversion of derivative security	-	5,750 Added 15.2%	32,086 Common Stock
Jan 09 2024	SELL Open market or private sale	$26,737 $22.99 p/Share	1,163 Reduced 4.23%	26,336 Common Stock
Jan 05 2024	BUY Exercise of conversion of derivative security	-	3,250 Added 10.57%	27,499 Common Stock
Aug 17 2023	SELL Open market or private sale	$168,060 $26.28 p/Share	6,395 Reduced 21.12%	23,890 Common Stock
Jun 30 2023	SELL Open market or private sale	$48,410 $28.36 p/Share	1,707 Reduced 5.34%	30,285 Common Stock
Jun 28 2023	BUY Exercise of conversion of derivative security	-	5,750 Added 15.24%	31,992 Common Stock
Mar 03 2023	SELL Payment of exercise price or tax liability	$28,247 $25.02 p/Share	1,129 Reduced 4.12%	26,242 Common Stock
Mar 01 2023	BUY Exercise of conversion of derivative security	-	3,833 Added 12.28%	27,371 Common Stock
Feb 16 2023	SELL Payment of exercise price or tax liability	$17,606 $28.91 p/Share	609 Reduced 2.52%	23,538 Common Stock
Feb 14 2023	SELL Payment of exercise price or tax liability	$18,286 $28.44 p/Share	643 Reduced 2.79%	22,409 Common Stock
Feb 14 2023	BUY Exercise of conversion of derivative security	-	1,738 Added 6.71%	24,147 Common Stock
Feb 10 2023	BUY Exercise of conversion of derivative security	-	1,834 Added 7.37%	23,052 Common Stock
Dec 28 2022	SELL Payment of exercise price or tax liability	$73,962 $28.48 p/Share	2,597 Reduced 10.9%	21,218 Common Stock
Dec 23 2022	BUY Exercise of conversion of derivative security	-	8,750 Added 26.87%	23,815 Common Stock
Feb 22 2022	SELL Payment of exercise price or tax liability	$6,252 $29.08 p/Share	215 Reduced 1.43%	14,793 Common Stock
Feb 22 2022	BUY Exercise of conversion of derivative security	-	724 Added 4.6%	15,008 Common Stock
Feb 14 2022	SELL Payment of exercise price or tax liability	$65,728 $30.5 p/Share	2,155 Reduced 13.11%	14,284 Common Stock
Feb 14 2022	BUY Exercise of conversion of derivative security	-	6,988 Added 29.83%	16,439 Common Stock
Feb 10 2022	SELL Payment of exercise price or tax liability	$20,209 $31.43 p/Share	643 Reduced 6.37%	9,451 Common Stock

JWB

James William Burns

Chief Legal Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGIO shares.

Notify only if

Value

Insider Trading

Get notified when an Agios Pharmaceuticals, Inc. insider buys or sells AGIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to AGIOS PHARMACEUTICALS, INC.

Track Activities on AGIO

Account